Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)

• Main Authors: Athanasios Tsianakas (Author), Claudia Zeidler (Author), Claudia Riepe (Author), Matthias Borowski (Author), Caroline Forner (Author), Joachim Gerss (Author), Martin Metz (Author), Petra Staubach (Author), Ulrike Raap (Author), Martin Kaatz (Author), Marc Urban (Author), Thomas A. Luger (Author), Sonja Ständer (Author)
• Format: Book
• Published: Medical Journals Sweden, 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The aim of this multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II study was to determine the antipruritic effect of aprepitant vs. placebo in 58 patients with anti-histamine-refractory chronic pruritus in chronic nodular prurigo. Patients were randomized to receive eith...